ConductScience.org, home

Paper36588698

Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling.

Grañana-Castillo S and 4 others. Front Pharmacol, 2022. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling. Papers, record 36588698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36588698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling.
PubMed
Journal
Front Pharmacol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2024-09-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grañana-Castillo SSandra
2Montanha MCMaiara Camotti
3Bearon RRachel
4Khoo SSaye
5Siccardi MMarco

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132638292Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis.Int J Clin Pharm2020https://conductscience.org/library/papers/32638292PubMed
234822220Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide.J Int AIDS Soc2021https://conductscience.org/library/papers/34822220PubMed
318775982Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling.Drug Metab Dispos2008https://conductscience.org/library/papers/18775982PubMed
432240629Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.Lancet HIV2020https://conductscience.org/library/papers/32240629PubMed
511158730Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11158730PubMed
622096405Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings.HIV AIDS (Auckl)2011https://conductscience.org/library/papers/22096405PubMed
733609656Pyridones in drug discovery: Recent advances.Bioorg Med Chem Lett2021https://conductscience.org/library/papers/33609656PubMed
832816220Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions.Clin Drug Investig2020https://conductscience.org/library/papers/32816220PubMed
926201299
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.
Lancet Infect Dis2015https://conductscience.org/library/papers/26201299PubMed
1012885263Whole body pharmacokinetic models.Clin Pharmacokinet2003https://conductscience.org/library/papers/12885263PubMed
1111868802Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.Eur J Clin Pharmacol2002https://conductscience.org/library/papers/11868802PubMed
1219307295Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells.Drug Metab Dispos2009https://conductscience.org/library/papers/19307295PubMed
1324060875Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/24060875PubMed
1435943252Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35943252PubMed
1533951360Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.N Engl J Med2021https://conductscience.org/library/papers/33951360PubMed
1620368326Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.Drug Metab Dispos2010https://conductscience.org/library/papers/20368326PubMed
1727799217Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/27799217PubMed
1824614383Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24614383PubMed
1933541517Anthropometric Reference Data for Children and Adults: United States, 2015-2018.Vital Health Stat 32021https://conductscience.org/library/papers/33541517PubMed
2026380154Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers.CPT Pharmacometrics Syst Pharmacol2015https://conductscience.org/library/papers/26380154PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41658591A clinically significant interaction between voriconazole and rifapentine: a case report and review of evidence.Front Med (Lausanne)2026https://conductscience.org/library/papers/41658591PubMed
40968422Application of Physiologically Based Pharmacokinetic Modeling in the Research of Anti-HIV Drugs.Curr Drug Metab2025https://conductscience.org/library/papers/40968422PubMed
40733576The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections.Viruses2025https://conductscience.org/library/papers/40733576PubMed
40560789Development and hepatotoxicity of rifamycin derivatives.Expert Opin Drug Metab Toxicol2025https://conductscience.org/library/papers/40560789PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AADAC13PubTator's text mininghttps://conductscience.org/library/genes/13NCBI Gene
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CYP2B61555PubTator's text mininghttps://conductscience.org/library/genes/1555NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
SLCO1B110599PubTator's text mininghttps://conductscience.org/library/genes/10599NCBI Gene
SLCO1B328234PubTator's text mininghttps://conductscience.org/library/genes/28234NCBI Gene
UGT1A154658PubTator's text mininghttps://conductscience.org/library/genes/54658NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36588698

GET https://conductscience.org/api/papers/v1/36588698/references?page=2